ImmunityBio’s Anktiva receives Saudi FDA approval for non-muscle invasive bladder cancer with carcinoma in-situ: Culver City, California Friday, January 16, 2026, 15:00 Hrs [IST ...
Diabeloop & Sequel Med Tech ink partnership to integrate US FDA-cleared DBLG2 into the twiist AID system: Grenoble, France Friday, January 16, 2026, 16:00 Hrs [IST] Following the ...
Gradalis announces positive results from phase 2b VITAL trial of Vigil to treat patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer: Dallas Friday, January 16, ...
Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid: Our Bureau, Chennai Friday, January 16, 2026, 17:15 Hrs [IST] In a significant crackdown on the illega ...
Westborough, Massachusetts Friday, January 16, 2026, 14:00 Hrs [IST] ...
US FDA grants Orphan Drug Designation to Adolore BioTherapeutics’ Kv7-activating rdHSV-CA8 therapy to treat erythromelalgia: Delray Beach, Florida Friday, January 16, 2026, 17:0 ...
ISCR urges Centre to prioritise stronger support to clinical research sector in Union budget 2026: Our Bureau, Bengaluru Friday, January 16, 2026, 14:15 Hrs [IST] Indian Society f ...
Manipal Hospital Bhubaneswar unveils surgical trust campaign on 11 years of complex interventions: Our Bureau, Bengaluru Friday, January 16, 2026, 14:45 Hrs [IST] Manipal Hospital ...
Boston Scientific enters agreement to acquire Penumbra for $14.5 billion: Marlborough, Massachusetts Friday, January 16, 2026, 14:30 Hrs [IST] Boston Scientific Corporation and Pe ...
GCCL and OPIS sign MoU to advance global clinical trial capabilities: South Korea Friday, January 16, 2026, 13:00 Hrs [IST] GCCL, a leading South Korea-based provider of clinical ...
Single-cell research of patients’ immune cells to guide future treatments: Dr Arivusudar John: Shardul Nautiyal, Mumbai Friday, January 16, 2026, 08:00 Hrs [IST] Single-Cell Ana ...
Top Employers Institute recognizes Boehringer Ingelheim as Global Top Employer 2026: Ingelheim, Germany Friday, January 16, 2026, 12:00 Hrs [IST] For the sixth year in a row, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results